Share chart CalciMedica, Inc.
Extended chart
Simple chart
About CalciMedica, Inc.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. more detailsIPO date | 2020-09-25 |
---|---|
ISIN | US38942Q2021 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.calcimedica.com |
Цена ао | 1.93 |
Change price per day: | 0% (1.94) |
---|---|
Change price per week: | -3% (2) |
Change price per month: | +25.97% (1.54) |
Change price per 3 month: | -22.71% (2.51) |
Change price per half year: | -42.6% (3.38) |
Change price per year: | -64.4% (5.45) |
Change price per 3 year: | +134.98% (0.8256) |
Change price per year to date: | -29.71% (2.76) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Orbimed Advisors LLC. | 297380 | 5.25 |
Bml Capital Management, LLC | 145424 | 2.57 |
Meritage Portfolio Management | 46000 | 0.81 |
Geode Capital Management, LLC | 13354 | 0.24 |
First Manhattan Company | 13226 | 0.23 |
Tower Research Capital LLC (TRC) | 1417 | 0.03 |
Morgan Stanley | 856 | 0.02 |
Bank of America Corporation | 507 | 0.01 |
Wells Fargo & Company | 16 | 0 |
Cutler Group LP | 14 | 0 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. A. Rachel Leheny Ph.D. | CEO & Director | 852.84k | 1963 (62 years) |
Mr. Eric W. Roberts | Chief Business Officer & Vice Chairman of the Board | 757.4k | 1964 (61 year) |
Dr. Anjana Rao Ph.D. | Co-Founder and Scientific Advisor | N/A | |
Dr. Patrick Hogan Ph.D. | Co-Founder and Scientific Advisor | N/A | |
Dr. Stefan Feske M.D. | Co-Founder and Scientific Advisor | N/A | |
Dr. Kenneth A. Stauderman Ph.D. | Co-Founder & Chief Scientific Officer | 615.59k | 1953 (72 years) |
Mr. Daniel E. Geffken M.B.A. | Interim Chief Financial Officer | N/A | 1957 (68 years) |
Mr. John M. Dunn J.D. | General Counsel | N/A | 1952 (73 years) |
Mr. Michael J. Dunn M.B.A., MBA | President & COO | N/A | 1956 (69 years) |
Dr. Sudarshan Hebbar M.D. | Chief Medical Officer | 1965 (60 years) |
Address: United States, La Jolla. CA, 505 Coast Boulevard South - open in Google maps, open in Yandex maps
Website: https://www.calcimedica.com
Website: https://www.calcimedica.com